Common Drug for PTSD Doesn’t Stem Nightmares, Sleep Problems in Veterans

Mclean Hospital

Reuters

McLean’s Chief Scientific Officer Dr. Kerry Ressler responds to the results of a new study that examined the effectiveness of a medication often used by veterans with chronic post-traumatic stress disorder.

Read Full Article

Topics

PTSD Trauma Kerry Ressler

McLean Main Navigation

In the Media: Common Drug for PTSD Doesn’t Stem Nightmares, Sleep Problems in Veterans

Reuters

Managing Anxiety and Stress in the Workplace and at Home

COVID-19 and Global Mental Health: Threats and Opportunities

Pushing Back Against Feelings of Loneliness

Staying Centered in Turbulent Times

In the Media: Common Drug for PTSD Doesn’t Stem Nightmares, Sleep Problems in Veterans

Reuters

You May Also Like

McLean Sponsors Maine Art Exhibit Focused on Domestic Abuse

Neuron-Based Gene Expression Study Reveals Insights on Fear and Its Regulation

Rockland Businesses Team Up With Artists for Domestic Violence Awareness Month

Study – MRI With Machine Learning Reveals Brain Changes From PTSD

Resources

Latest Videos

Managing Anxiety and Stress in the Workplace and at Home

COVID-19 and Global Mental Health: Threats and Opportunities

Pushing Back Against Feelings of Loneliness

Staying Centered in Turbulent Times

Keep Up With McLean!